Page 86 - GPD-3-3

Gene & Protein in Disease Next gen (omics)

genetic counseling and education by offering personalized, RNA sequencing (RNA-Seq) and microarray-based gene
on-demand support. By automating family health histories expression profiling have become routine methods that
and gathering and identifying individuals at risk of genetic are still under constant improvement. These methods have
conditions, chatbots liberate genetic counselors from the been crucial in identifying differentially expressed genes
shackles of complex and tedious data analysis so that they and pathways in various conditions, such as breast cancer.
focus on delivering patient care. 10 Modern digital tools play a pivotal role in advancing
transcriptomic profiling. As an example, single-cell RNA-
3.2. Clinical trials for rare diseases Seq enables large-scale transcriptomic analysis at the single-

Digital health technologies can be used to enhance the cell level, providing insights into cellular heterogeneity and
14
design and operation of clinical trials for genetic diseases, gene expression patterns. Transcriptomic profiling has
which often face challenges such as patient recruitment proven to be an effective method, which is expected to
and complex workflows given the rarity of the diseases. become more beneficial to users if enhanced with further
Tools such as EHR-based patient recruitment, interactive digital elements.
websites, televisit platforms, and wearable devices are being
employed to streamline trial processes. These technologies 3.5. Digital genomics for advanced population
can reduce the time spent on genetic counseling, lower genetic profiling
health-care costs, and improve the efficiency of clinical Populations across the globe exhibit diverse genetic and
11
trials. By leveraging real-world data and linking them genomic profiles, which reflect unique evolutionary
with biological sample repositories, registries and “life histories and environmental exposures. Understanding
questionnaires” (Quality of life) provide insights into these population-specific genomic variations is crucial for
disease progression and prevalence, helping to identify delivering precise and targeted health-care interventions.
potential trial participants and monitor their progress. By tailoring medical treatments and preventive strategies
These capabilities significantly expedite the development based on genomic data, health-care providers can enhance
of new treatments and therapies for genetic diseases. the effectiveness of care, reduce adverse drug reactions,
and optimize outcomes for patients. This genomic-based
15
3.3. Linking mental health with digital genomics approach also holds significant promise for diminishing
In recent years, there has been a growing global awareness health-care disparities by ensuring that underrepresented
of mental health issues. Various studies and initiatives have and minority populations receive appropriate and effective
highlighted the importance of addressing mental health care, addressing historical gaps in health-care quality.
16
challenges due to their impact on the well-being of the Digital tools have proven instrumental in managing and
affected population. Studies address the double-sided analyzing large-scale genomic data. These tools facilitate the
12
need for increasing social acceptance of mental health integration of genomic information into clinical practice,
issues, and the elaboration of systematic and scalable streamline research processes, and enable the rapid
approaches to prevent mental illnesses from degenerating. 13 sharing of findings across global research communities,
Recent studies have started exploring the impact of thus supporting the delivery of equitable and personalized
genetics and genomics on mental health and the possibility health-care solutions.
of understanding a patient’s predisposition to mental 4. Strategies for managing challenges in
illnesses based on their genetic contour, with the objective
of improving the understanding and treatment of a patient’s AI-driven genetic research
condition. Therefore, digitalization enhances the ability to There are numerous challenges currently impeding the
provide deeper insights into the genetic underpinnings widespread adoption and implementation of digital health
of mental health conditions. This, in turn, supports the interventions in the field of genetic diseases, most of which
development of personalized treatment plans, predictive are privacy concerns. Since genetic data are profoundly
tools, and scalable public health strategies, ultimately personal and privacy-sensitive, their utilization will
improving mental health outcomes on a broad scale. bring forth significant privacy apprehensions. Patients
may be reluctant to share their genetic information,
3.4. Transcriptomic digital profiling particularly when uncertain about its utilization or the
Transcriptomic analyses are used to offer a systemic entities with access to it (Figure 1). Furthermore, there
snapshot of a patient’s condition, such as cancer or other currently is no standardized framework for the collection,
malignancies. Methods used to analyze RNA expression storage, and analysis of genetic data. This absence of
levels in cells, tissues, or organisms have seen significant standardization renders comparison and sharing of data
advancements in recent years, and techniques such as across various health systems and institutions arduous,

Volume 3 Issue 3 (2024) 4 doi: 10.36922/gpd.4128